Amylin appears to be responsible for the obesity, reduced insulinsecretion and the reduced effectiveness of insulin observed in TypeII diabetes, he said.
Scientists already knew of another pancreatic hormone that blocksinsulin, but it is not found in abnormal levels in diabetics, saidPi-Sunyer, director of the endocrinology, diabetes and nutritiondivision at St. Luke's-Roosevelt Hospital Center in New York.
